Israel - English - Ministry of Health

cts chemical industries ltd, israel - valproic acid as sodium - solution (oral) - valproic acid as sodium 200 mg/ml - valproic acid - treatment of generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.

Canada - English - Health Canada

endo ventures ltd. - tapentadol (tapentadol hydrochloride) - tablet (immediate release) - 50mg - tapentadol (tapentadol hydrochloride) 50mg - opiate agonists

Canada - English - Health Canada

endo ventures ltd. - tapentadol (tapentadol hydrochloride) - tablet (immediate release) - 75mg - tapentadol (tapentadol hydrochloride) 75mg - opiate agonists

Canada - English - Health Canada

endo ventures ltd. - tapentadol (tapentadol hydrochloride) - tablet (immediate release) - 100mg - tapentadol (tapentadol hydrochloride) 100mg - opiate agonists

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sodium valproate, quantity: 500 mg - tablet, enteric coated - excipient ingredients: hyprolose; calcium silicate; amaranth aluminium lake; titanium dioxide; polyvinyl acetate phthalate; diethyl phthalate; stearic acid; purified talc; povidone; hypromellose; magnesium stearate; macrogol 6000; indigo carmine aluminium lake; citric acid monohydrate - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sodium valproate, quantity: 200 mg - tablet, enteric coated - excipient ingredients: citric acid monohydrate; polyvinyl acetate phthalate; indigo carmine aluminium lake; hyprolose; magnesium stearate; povidone; stearic acid; amaranth aluminium lake; diethyl phthalate; purified talc; macrogol 6000; calcium silicate; hypromellose; titanium dioxide - epilepsy: primary generalised epilepsy (petit mal absences, various forms of myoclonic epilepsy and tonic-clonic grand mal seizures). partial (focal) epilepsy either alone or as adjuvant therapy. mania: for the treatment of mania where other therapy has proved inadequate or is inappropriate.

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - risperidone -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - risperidone -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - risperidone -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - risperidone -